Member Info for EmeraldCarrots

Hope they are buy's!

The other day. Prev my average was a shade over 2p. I expect the vote to be yes. On that the sp I think will improve as at least the funding options are increased. I don't expect it to go 1.5p or anything like that though. A window of say 4 months should ensure the FDA application goes in for the MT-RNR1 which is all important. If Gino pulls out all the stops maybe the application will go in within say 6 weeks. That is what is relly needed. Then there is the prospect of FDA approval before xmass. This will instantly make Genedrive a far more valuable company. £ millions. While this is going on we will get the Scottish rollout in full swing.

All IMHO.

For the application. Why has it NOT been done? Why can't it be done in the next say 6 weeks? Why? I really want to know as we have been waiting 1 year and 2 months so far! Incredible. They should see the earliest they can put the application together then do an RNS to confirm they intend to bring the application forward.

All IMHO.

They are responsible for not progressing the FDA application, it is unforgivable.

All IMHO.

Slacker246

Do you really think he is that stupid??.

This is gameplay with every move considered and planned!!

Only losers will be dumb money!!

================================

I'm beginning to think he is that stupid to be honest. How can ANY Plc get a "FDA breakthrough device designation" and NOT move heaven and earth to get it submitted? Genedrive Plc with Gino at the helm. No rush! It's only been ***one year and two months*** !!!!!!!!!!!!!!!!!!!!!!!!!!!

Maybe he is an idiot?

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

All IMHO.

Up 5.88%

ButterMyCrumpets.

In reply to you I believe they have all they need already, or will have within a few months. It is just the Directors have prioritised the NHS over the FDA applications. They probably saw/see the NHS as "real money" and don't even realise an FDA application would have brought in American shareholders. That almost certainly would have propped up the share price. That is also "real money" in that a placing could have been done at 1.5p or above. Unforgivable basic error by inexperienced Directors. Ian Gilham should have known this.

All IMHO.

Cancer solid tissue tumour profiling analysis. If Myriad want to do this then it follows that other Genetic analysis Plc's do, or will do in the future. Myriad is a NASDAQ listed USA Company. Angle's Parsortix catches alive, intact, uncontaminated circulating tumour cells (CTC's) that are perfect for DNA analysis. That is why Myriad are collaborating with Angle Plc.

Note Angle have/are also working with Illumina, one of the largest DNA analysis Companies in the World.

Not much more one can say apart from the results tomorrow will be very interesting.

All IMHO.

Is recommended to use in the NHS if the genedrive machine is not availabe........................

Surely they will bid.

=====================

Point-of-care testing

1.4 Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

1.5 Use the ****Genomadix Cube point-of-care test**** when laboratory-based testing and the Genedrive CYP2C19 ID Kit point-of-care test are not available.

=====================

https://www.nice.org.uk/guidance/dg59/chapter/1-Recommendations

https://genomadix.com/

MIKODX.

Unless Gino is an idiot, and I'm not sure on that, he should pull out all the stops and put the FDA application in for the MT-RNR1. If not he won't have a job, or a Company to run. It's as simple as that. I hope being made redundant and Genedrive going broke will spur him on. Unless he is a complete fool.

All IMHO.

Gino should NOT be the CEO here. Ian Gilham must have been involved in his appointment, following all the other CEO's he was also involved with appointing who have not worked out. Their failure to prioritise the FDA applications is unforgivable. My view if Russ Shaw should be the CEO. He knows better than anyone where the money is being spent. Gino should be the Chief Scientific Officer. Ian Gilham should be replaced.

All IMHO.

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

They can send in supporting "real use" data when they have it from the NHS and anything else. Frankly they should easily have that NOW. Any application must involve queries from the FDA and responses from the applicant. What in the World is Gino doing? PUT THE APPLICATION IN NOW!

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

All IMHO.

They can send in supporting "real use" data when they have it from the NHS and anything else. Frankly they should easily have that NOW. Any application must involve queries from the FDA and responses from the applicant. What in the World is Gino doing? PUT THE APPLICATION IN NOW!

All IMHO.

Portfolio

Manage

Voting maibox

Vote

Is largely responsible for appointing the Directors, and there have been a few! He has been Chairman for many years........... In my opinion Gino should not be CEO. He should have been the Technical Director working towards the FDA applications which no doubt would include adapting the MT-RNR1 to 115 volt etc... What is he doing at these conferences promoting the machines in the Middle east?? You could not make it up. That is what the salespeople do (or not at this Company!!). I feel sorry for Russ as he gets the blame when the Chairman has a revolving door for CEO's, the sales staff would struggle to sell a cold bottle of water to a person dying of thirst in the desert and no one has the faintest idea how important FDA clearance in the USA is.

Hopefully we will gat a reasonable bid to take us over (2 to 3p a share). Then they will sack probably all the Directors, and the sales staff.

All IMHO.

A.I.

how many tumour profiling tests do myriad genetics do a year?

For the full year ending December 31, 2024, Myriad Genetics performed 53,000 tumor profiling tests. The Precise Tumor test is part of the oncology business segment, which includes its tumor profiling category.

================

Interesting. 53,000 a year / 365 = 146 tests / tubes of blood per 24 hour day.

Parsortix processes 1 tube blood in 2 hours.

So 6 tubes of blood to process per 12 hour day.

146 tests / 6 tubes per 12 hour day = 24 machines may be needed.

So 4 tubes of blood per 8 hour day.

146 tests / 4 tubes per 8 hour day = 36 machines may be needed.

Plus the consumables which includes the $250 ish cassette filter.

Could end up a considerable payment for the machines. Say 24 machines @ $55,000 = £1,320,000

Plus a steady income from the consumables. 53,000 x $250 (cassette cost) = $13,250,000 per year.

All IMHO.

All IMHO.

Is recommended if the genedrive machine is not availabe!!!

Surely they will bid.

Point-of-care testing

1.4 Use the Genedrive CYP2C19 ID Kit point-of-care test for CYP2C19 genotype testing when laboratory-based testing is not available.

1.5 Use the Genomadix Cube point-of-care test when laboratory-based testing and the Genedrive CYP2C19 ID Kit point-of-care test are not available.

https://www.nice.org.uk/guidance/dg59/chapter/1-Recommendations

https://genomadix.com/

So one YEAR and nearly two months later no application even gone in to get the machine cleared for sales in the USA. Beggars belief. I believe if an application for either machine had been done we would not be in this mess. Would have pulled is USA investors. An attitude of excuses rather than getting it done from where I'm sitting.

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

JimiHendrix.

I note you are Mr doom and gloom. The FDA are not overseeing the NHS trial, and no doubt data is gathered week by week, month by month and sent back to Genedrive, or at least they are copied in. It is not secret data. Also, the MT-RNR1 has been in use for what, 1.5 years or more at various hospitals in the NHS. I can't see any way that NHS data can't be used for the FDA application. I am truly astounded Gino and Russ don't seem to even understand how important the FDA application is. It is far more than what it seems. An FDA application for the MT-RNR1 WILL GET USA INVESTORS ON BOARD. If an application had even just gone in for it, we would NOT be in this situation. It is a totally incompetent of the board, beggars belief. However the machine exists, the NHS data is there and if Gino still wants to have a job in 2 months time, he had better sort an application out. It is not as if it is impossible. Far from it.

All IMHO.

I would like to know as we are aware they can use data generated in the NHS and we should have shed loads of that by now. Why to hold up? Seems crazy. If they do an update I want them to announce they are bringing forward the application. Next week would be good! LOL!